NepafenacThird Party Manufacturing in India

Nepafenac works by acting as an advanced prodrug designed to easily penetrate the cornea. Once it passes through the corneal structure, intraocular hydrolases rapidly convert nepafenac into amfenac, a potent non-steroidal anti-inflammatory drug. Amfenac inhibits cyclooxygenase-1 and cyclooxygenase-2 enzymes, stopping prostaglandin synthesis in the iris, ciliary body, and retina. Unlike traditional topical NSAIDs that cause surface irritation, its inactive prodrug structure minimizes corneal surface toxicity while delivering deep targeted intraocular anti-inflammatory action. It is highly effective and well-tolerated.

Therapeutic Uses

• Post-Operative Cataract Pain: Controls pain and prevents inflammation following routine or complex cataract extraction procedures.
• Macular Edema Prevention: Reduces the risk of post-surgical macular swelling in diabetic patients undergoing eye surgeries.
• Intraoperative Miosis Prevention: Maintains steady pupillary dilation during prolonged surgical procedures.

Why Manufacturers Choose Nepafenac

Nepafenac is preferred by premium ophthalmic practices due to its prodrug target delivery, making it a valuable addition to standard surgical kits. Investing in Nepafenac third party manufacturing in India enables marketing firms to secure steady contract orders from eye care centers. Our partner facilities are WHO-GMP certified, utilizing advanced particle-size milling to guarantee uniform suspension and prevent clumping of the CAS 78281-72-8 active ingredient.